Devic's neuromyelitis optica in an infant case.
Devic's neuromyelitis optica was orginally described as an acute severe monophasic syndrome characterised by myelitis and optic neuritis. The mean age at onset was reported to be around 40 years, with a wide range. However, Devic's neuromyelitis optica has also been seen in children. Prognosis of the syndrome was poor, and no satisfactory treatment was known. This article reports a 23-month-old boy with acute myelitis and optic neuritis who was diagnosed with Devic's neuromyelitis optica. The response of the patient to therapy was poor, and he developed severe sequelae.
Yuksel
Deniz
D
Department of Pediatric Neurology, Dr Sami Ulus Children's Health and Diseases Training and Research Hospital, Ankara, Turkey. drdeniz_yuksel@yahoo.com.tr
Senbil
Nesrin
N
Yilmaz
Deniz
D
Yavuz Gurer
Y K
YK
D001284:Atrophy / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D020278:Demyelinating Autoimmune Diseases, CNS / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008297:Male; D018908:Muscle Weakness / Q000276:immunology / Q000503:physiopathology; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D009900:Optic Nerve / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology; D011239:Prednisolone / Q000627:therapeutic use; D012128:Respiratory Distress Syndrome / Q000276:immunology / Q000503:physiopathology; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology; D016896:Treatment Outcome; D014786:Vision Disorders / Q000276:immunology / Q000473:pathology / Q000503:physiopathology
D007166:Immunosuppressive Agents; D011239:Prednisolone